An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act

This bill is from the 40th Parliament, 3rd session, which ended in March 2011.

Sponsor

Paul Dewar  NDP

Introduced as a private member’s bill. (These don’t often become law.)

Status

Second reading (Senate), as of March 24, 2011
(This bill did not become law.)

Summary

This is from the published bill.

This enactment amends the Patent Act to make it easier to manufacture and export pharmaceutical products to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other epidemics.

Similar bills

C-398 (41st Parliament, 1st session) An Act to amend the Patent Act (drugs for international humanitarian purposes)
S-208 (41st Parliament, 1st session) An Act to amend the Patent Act and the Food and Drugs Act (drugs for international humanitarian purposes)
C-393 (40th Parliament, 2nd session) An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
S-232 (40th Parliament, 2nd session) An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-393s:

C-393 (2024) An Act to amend the Canadian Environmental Protection Act, 1999 (electronic products recycling program)
C-393 (2018) An Act to amend the Canadian Multiculturalism Act (non-application in Quebec)
C-393 (2013) Railway Noise and Vibration Control Act
C-393 (2012) Railway Noise and Vibration Control Act

Votes

March 9, 2011 Passed That Motion No. 3 be amended by deleting all the words after the words “The provisions of this Act that amend the Patent Act” and substituting the following: “shall cease to apply on the day that is the tenth anniversary of the day on which this Act comes into force unless, before that day, the application of those provisions is subject to a comprehensive review by the standing committee designated by the House of Commons for that purpose, that committee recommends that they be maintained and the House of Commons approves that recommendation.”.

Paul Dewar NDP Ottawa Centre, ON

Mr. Speaker, elected members of Parliament, including 26 Conservatives, voted to save lives by passing Bill C-393, the medicines for all bill.

However we have obtained an email drafted by the industry minister directing Conservative senators to kill the bill. Conservatives are again using the Senate, a relic of the 19th century according to the Prime Minister, to kill a bill this House passed. Conservatives are putting profits for the big drug companies against saving lives.

Do the Conservatives understand democracy, or do they just not like it?

Freezing Assets of Corrupt Foreign Officials ActGovernment Orders

March 10th, 2011 / 10:25 a.m.


See context

NDP

Paul Dewar NDP Ottawa Centre, ON

Mr. Speaker, I join with my colleagues in supporting the fast-tracking of this bill. I also want to mention the importance of having this review. From the beginning, it was our party's position that this needed a review. We are talking about significant changes, albeit ones that are needed. When we are moving rapidly to make changes like these, it is important that Parliament have an opportunity for review.

I also want to recognize the public servants who worked on this matter. Often they are not given the accolades they deserve. When these things happen, we all know who does the detailed work. I want to thank the officials at the Department of Justice and the Department of Foreign Affairs, those who were willing and able to brief us and appear at committee.

There is no doubt this is a phenomenon we will have to deal with in a different way in terms of legislative tools. This is important. We also have to acknowledge that assets exist here from questionable regimes. In particular, we are seeing a kind of strong-arm phenomenon, in that individuals who are using the profits from ill-gotten gains are often supported by companies from the west. These have to be scrutinized more closely. FINTRAC is one means, but we need something that is a lot more precise.

I would note that the government did bring in measures on arms restrictions banning exports to Libya. It is important to note that to date, the government has not brought forward to Parliament, and therefore Canadians, a report on our arms exports as a country. That has to happen.

I would also mention that this bill has to go through the Senate quickly. I would hope that would be done with Bill C-393 as well.

Access to MedicinesStatements By Members

March 9th, 2011 / 2:10 p.m.


See context

NDP

Megan Leslie NDP Halifax, NS

Mr. Speaker, women and girls continue to be affected disproportionately by HIV and AIDS in sub-Saharan Africa. Better access to life-saving medicines would greatly benefit mothers and children living with HIV and AIDS, as well as help family members, particularly grandmothers caring for their grandchildren.

Bill C-393 proposes a one-licence solution that would greatly simplify the licensing process to export lower-cost generic medicines to developing countries.

I would like to recognize the support of this bill by the strong national network of grandmothers groups which seek to build solidarity, raise awareness and mobilize support in Canada for Africa's grandmothers. These women have built a strong two-way relationship that has proven to be a powerful challenge to a pharmaceutical industry that prioritizes profits over human rights, health, social and economic justice.

I hope that the actions of these grandmothers and of all women and girls working in solidarity with each other around the world will inspire the members of this House to pass Bill C-393.

Access to MedicinesStatements by Members

December 1st, 2010 / 2:15 p.m.


See context

NDP

Chris Charlton NDP Hamilton Mountain, ON

Mr. Speaker, today is World AIDS Day, and in communities such as Hamilton, grandmothers are gathering in support of Bill C-393. The purpose of this bill is to ensure that life-saving medicines reach those who need them most. By simplifying the export of cheap, generic, antiretroviral drugs to the countries of sub-Saharan Africa, this bill literally could turn the tide of HIV-AIDS.

Sadly, a few weeks ago, the Liberal opposition teamed up with the Conservative government to gut Bill C-393. In committee, the Liberal-Tory coalition stripped the most critical element, the one-licence provision, from the bill.

While I try to avoid excessive partisanship, this is a profoundly partisan matter. There is no sugaring the pill: across Africa, people are dying from preventable diseases. Children are dying from treatable illness. They desperately need the medicines we have and they need them now.

I urge my Liberal and Conservative colleagues to do the right thing. There is no downside. By restoring the one-licence solution and passing the bill immediately, millions of lives can be saved. Brand-name companies will receive royalties for their intellectual property, and generic drug companies will increase their capacity and employment, all without costing Canadian taxpayers a dime.

Rarely do we as MPs have such personal power to save millions of lives. Let us use that power wisely.

Industry, Science and TechnologyCommittees of the HouseRoutine Proceedings

November 1st, 2010 / 3:05 p.m.


See context

Conservative

David Sweet Conservative Ancaster—Dundas—Flamborough—Westdale, ON

Mr. Speaker, I have the honour to present, in both official languages, the ninth report of the Standing Committee on Industry, Science and Technology, in accordance with its order of reference on Wednesday, March 3, 2010.

Your committee has considered Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act and agreed on Monday, November 1, 2010, to report it, with amendments.

Canada Consumer Product Safety ActGovernment Orders

October 29th, 2010 / 12:40 p.m.


See context

NDP

Megan Leslie NDP Halifax, NS

Mr. Speaker, I am pleased to rise today to speak to this bill, because it means that it is one step closer to becoming law.

The NDP has advocated for consumer protection for years. Judy Wasylycia-Leis, my former colleague, the former member for Winnipeg North, has been on this file for years, advocating for stronger consumer protection. I know that our leader has raised it with the Prime Minister, and in the 40th Parliament, this session, the member for Sudbury has been a strong advocate for changes to consumer protection laws that would actually result in protection for consumers.

As we have heard a few times in this House, the previous legislation is 40 years old. It is time for a change. It is time to catch up and modernize. All parties are in agreement that this legislation is desperately needed.

However, that does not necessarily ensure that product safety is going to be ensured in Canada. This legislation is going to need to be enforced in order for it be effective. As the member for Elmwood—Transcona has said, there are serious questions about whether or not enforcement is actually going to happen and whether or not sufficient resources are going to be put into this bill.

This is a good bill. I am proud to support it. Our party is proud to support it. I am proud that it is going to the other place and may soon get royal assent. We are hopeful that it will be soon. However, we need to stop and think critically about whether this bill is just a shell being carried into effect for show, or whether it will actually provide protection for consumers.

There are a number of reasons to think that the government might abdicate its responsibility on this bill, should it be passed through the other place. The reason is this: despite the fact that the legislation is their own, and despite their repeated statements that this legislation is important to them, the Conservatives have dragged their feet. There is no other way of putting this. They have dragged their feet in introducing this legislation to the session. Previously, they prorogued Parliament and killed similar legislation, not once but twice. There was significant delay in getting this to first and second reading.

Now we are rushing it through. I think that is fair. We know what is in this bill. It has been to committee before. We have debated it before. However, it has taken a long time for us to get to this point.

Even though we are at third reading now, we have to ask why has this process has taken so long. Why has the government not acted quickly on this legislation, when there have been many opportunities to do so? I think it demonstrates a level of unwillingness to emphasize the safety of Canadians. It is disconcerting that so much time and energy, resources and effort, were put into trying to eliminate the gun registry, while product safety was put on the back burner.

The member for Portage—Lisgar is driving around in a minivan saying “End the registry”. In fact, that minivan was idling outside of Confederation Building the other day, so clearly they do not care about the environment either. There is no minivan saying “protect consumers”. There are no flyers going into other ridings, no radio or TV ads saying that we should protect consumers. All we get is foot-dragging.

Over the last month, we have received alarming reports about Health Canada's failure to warn parents about the risks of cadmium in children's jewellery. Health Canada testing showed unacceptable cadmium levels much earlier than we had previously known. Some of the products that they tested had cadmium levels of 93%, and yet the government delayed letting Canadians know about this. This is children's jewellery, and we all know what children do with small objects. It goes right in the mouth.

Health Canada has actually stated that cadmium is more toxic than lead. Testing that revealed unacceptable cadmium levels occurred in the 2009-10 testing cycle. But that was not the first time it was discovered. The previous testing cycle also revealed unacceptable cadmium levels. Health Canada advisories until now have not mentioned any of these test results. It is hard to imagine. These tests were on children's jewellery.

Our children were at danger of ingesting cadmium from these products because of the government's lack of transparency on testing and a lack of public education on cadmium's dangers. This is just plain wrong. It is irresponsible. I cannot understand why the government would not have mentioned these test results, especially when there was a 93% level in some products containing cadmium. The risks were inherently clear.

How can we trust the government to be the guardians of public safety under this new regime that Bill C-36 offers, when it failed to warn the public that its own tests were revealing cadmium in children's products?

The bill is good, but it is going to require significant resources in order to be effective. It is going to require an adequate number of inspectors and a team that is able to respond effectively to product safety concerns. They will have to respond in such a way that every Canadian will be kept safe from dangerous products.

It goes without saying that the government has done poorly on similar files, like food inspection. We should be questioning the Conservatives' willingness to fund product safety protections adequately. So it is a step forward, but without teeth. Without the systems in place to carry out the intended functions, it is going to be a colossal failure.

We will see the government trumpet the bill's passage and send a message to Canadians that their products are safe, but this message needs to be backed up with funding. It needs to be backed up with resources. Otherwise, we will be giving Canadians a false sense of security.

I stand here representing the voices of consumers from coast to coast to coast. I thank the government for finally bringing in this legislation, and I ask that they commit the resources to enforce it. Otherwise, the bill will be meaningless. I desperately hope that two, five, or ten years from now we are not lamenting a failure to act and saying “I told you so”.

I was reading the newspaper today and there was a quote by James Orbinski. It was not about this bill. It was about the access to medicines regime, Bill C-393. It was brought forward by my former colleague, Judy Wasylycia-Leis, but is now being handled by my colleague from Windsor West. Bill C-393, if passed, would facilitate selling developing countries generic drugs still under patent. It would fix the 2005 regime that was created by the Martin government. The bill should be supported by all members who believe in justice and fairness.

James Orbinski is the co-founder of Dignitas and a world-renowned health activist. In referring to Bill C393, he inadvertently said something related to Bill C-36: “Right now CAMR is a rhetorical success and a practical failure. Bill C-393 is an effort to make CAMR a practical success”. I read that and thought of Bill C-36. We must not let it become a rhetorical success but a practical failure. We need to ensure that there are resources in place.

I talked about justice and fairness. The bill should also raise levels of justice and fairness for low-income Canadians. It goes without saying that dangerous products touch the lives of socio-economically disadvantaged Canadians proportionately more than the rest of society. Cheap products rely on cheaper manufacturing processes, and these products are wreaking havoc on the lives of people who cannot afford better choices. These people are poorly positioned to deal with health consequences or with wages lost due to taking time off from work to care for themselves or their loved ones.

I believe strongly that product safety should not just be the prerogative of the rich. This issue goes to the heart of the equality principles held by Canadians, and product safety legislation should play a central role in moving toward economic justice in our country.

I would like to touch on an issue that I do not think has been raised in the House very often. Sometimes when I am out in the community I am approached by people who say that they have problems with Bill C-36. They see some constitutional issues they would like to see addressed; they are worried about the constitutionality of this legislation.

Recently, the member for Sudbury raised this constitutionality issue with lawyers who appeared at committee, asking whether we had to worry about this. According to the lawyers, there were no constitutional problems with this bill, nothing really to worry about.

The last time around, when this bill was called Bill C-6, it made it through the House and was then sent to the other place. When senators considered the bill at committee, the Public Interest Advocacy Centre made a presentation on this specific issue. It is not only important for members of the House to understand some of the constitutional issues that were raised, but also some thorough analysis would show, that we really do not need to worry about.

For background, the Public Interest Advocacy Centre is a non-profit organization that was established in 1976. Its mandate is to enable the representation of ordinary and vulnerable consumers when decisions are made concerning the important products and services they obtain. Of course, they are a natural organization to turn to when we consider product safety, whether it is legislation, regulation or action.

PIAC made a formal written presentation to the senate committee and I will read from the memorandum it submitted. I reads:

It is particularly disheartening to find the oppositional posture to this Bill presented as a matter of protection of the civil rights of business and property owners engaged in the sale and distribution of the consumer products that are the subject matter of this bill. Such individuals are amply protected by the provisions in the Canadian Charter of Human Rights and possible civil remedies for government behaviour that exceeds the ambit of its protective statutory mandate. Monetary loss, embarrassment and hurt feelings are regrettable, but nonetheless compensable in the event of improper government conduct.

On the other hand, harm caused to public health and citizen livelihood may only be imperfectly remedied. What will be the explanation given to a parent grieving the loss or permanent injury of a child caused by the use of a product irresponsibly brought to market, when the reason is the lack of, or delay in application, of proper enforcement tools by the responsible authority caused by these amendments? There is no guarantee that even an inadequate remedy of compensation may be available in the event of a breach of health and safety requirements that is of such widespread effect that it is ultimately financially ruinous of the supplier.

The rights of defendants in circumstances where criminal and/or quasi-criminal related behaviour may be involved are important, particularly in relation to the consequences that may be visited upon a defendant. But it is decidedly inappropriate to expose innocent Canadian consumers to potentially negligent market behaviour because of the fear that government inspectors may lack either the appropriate motive or skills of enforcement. It is a grievous misallocation of the Senate's legislative superintendence to cater to the misplaced fears of a few over the real health and safety concerns of the many potentially at risk. PIAC urges the Senate to reject the amendments of the committee and adopt Bill C-6 without change.

Michael Janigan, the executive director of PIAC, has his name at the bottom of the memo. That is a good positioning of the two sides that we have to balance here. We need to look out for the consumer protection of Canadians. We need to ensure that people can rely on the fact that their products are safe. It is absolutely imperative. I think he did a great job of showing the balance that has to be struck between the two and where, ultimately, how justice would bring us to the one side.

It is a great summary of the constitutional arguments and I really do support the perspective of PIAC. Thanks should be extended to PIAC for getting involved in this issue and contributing to the discussion in the other place.

I am strongly supportive of Bill C-36. It is an excellent framework. We need to move forward after 40 years of old legislation that is not modern. Ultimately, we cannot make this a rhetorical success but a practical failure. We need to ensure that the government puts adequate resources behind this bill to ensure it is a success for all Canadians.

Access to Medicines RegimePetitionsRoutine Proceedings

June 7th, 2010 / 3:25 p.m.


See context

NDP

Brian Masse NDP Windsor West, ON

Mr. Speaker, it is an honour for me to table a petition on Bill C-393 regarding the reform of Canada's access to medicines regime.

Fourteen thousand women, men and children die every day from infectious diseases such as tuberculosis, malaria, HIV and AIDS. This country has yet to fix Canada's access to medicines regime which was created a number of years ago, back in 2003, which still has not helped provide access to low cost medicines for those abroad. We are literally letting children, women and men suffer unnecessarily.

The petitioners call upon Canada to reverse its policy and to become a contributor to the health and well-being of those individuals as opposed to ignoring them.

Industry, Science and TechnologyCommittees of the HouseRoutine Proceedings

June 2nd, 2010 / 3:40 p.m.


See context

Conservative

Michael Chong Conservative Wellington—Halton Hills, ON

Mr. Speaker, I have the honour to present, in both official languages, the second report of the Standing Committee on Industry, Science and Technology, concerning its study of Bill C-309, An Act establishing the Economic Development Agency of Canada for the Region of Northern Ontario. The committee requests an extension of 30 days to be able to properly study the bill.

I also have the honour to present, in both official languages, the third report of the Standing Committee on Industry, Science and Technology, in relation to its study of Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act.

The committee requests a 30-day extension in order to give the bill proper consideration and to hear all witnesses who wish to appear.

Access to Medicines RegimePetitionsRoutine Proceedings

April 30th, 2010 / 12:05 p.m.


See context

NDP

Judy Wasylycia-Leis NDP Winnipeg North, MB

Mr. Speaker, I am very pleased to be able to table my very last petition in the House before I leave this place after 13 years. Actually, this will be the very last time that I will say anything on the official record of the House of Commons. I cannot think of a better issue around which to do this than on the matter raised by petitioners from my constituency and across Canada, particularly from the Canadian Grandmothers for Africa organization.

The petitioners call upon this House to follow through with the support that it gave Bill C-393, my private member's bill on the access to medicines regime, to ensure that more drugs flow at costing rates to Africa and other developing nations.

Members will know that this bill was supported by the House of Commons at second reading. It has gone to committee and the petitioners implore members of the House from all parties to see the process through, to discuss this matter at committee, to call witnesses, and to ensure that we change Canada's access to medicines regime to ensure that drugs flow to countries in need and to ensure that Canada lives up to its reputation as a leader in terms of humanitarian and compassionate issues around the world.

I thank all of those who have worked so hard on this issue, especially the grandmothers across Canada. I urge the House to help me leave this as a lasting legacy for all Canadians and the world.

The Speaker Peter Milliken

I would like to make a statement concerning private members' business. Standing Order 86.1 states that all items of private members' business originating in the House of Commons that have been listed on the order paper during the previous session shall be deemed to have been considered and approved at all stages completed at the time of prorogation.

In practical terms, this means that notwithstanding prorogation, the list for the consideration of private members' business established at the beginning of the 40th Parliament shall continue for the duration of this Parliament.

All items will keep the same number as in the first and second sessions of the 40th Parliament. More specifically, all bills and motions standing on the list of items outside the order of precedence shall continue to stand. Bills that had met the notice requirement and were printed in the order paper, but had not yet been introduced, will be republished on the order paper under the heading “Introduction of Private Members' Bills”. Bills that had not yet been published on the order paper need to be re-certified by the office of the Law Clerk and Parliamentary Counsel and be resubmitted for publication on the notice paper.

All items in the order of precedence are deemed to have been considered and approved at all stages completed at the time of prorogation. Thus, they shall stand, if necessary, on the order paper in the same place or, as the case may be, referred to the appropriate committee or sent to the Senate.

At prorogation, there were 11 private members' bills originating in the House of Commons adopted at second reading and referred to the appropriate committee. Therefore, pursuant to Standing Order 86.1: Bill C-290, An Act to amend the Income Tax Act (tax credit for loss of retirement income), is deemed referred to the Standing Committee on Finance.

Bill C-300, An Act respecting Corporate Accountability for the Activities of Mining, Oil or Gas in Developing Countries, is deemed referred to the Standing Committee on Foreign Affairs and International Development.

Bill C-304, An Act to ensure secure, adequate, accessible and affordable housing for Canadians, is deemed referred to the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities.

Bill C-308, An Act to amend the Employment Insurance Act (improvement of the employment insurance system), is deemed referred to the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities.

Bill C-309, An Act establishing the Economic Development Agency of Canada for the Region of Northern Ontario, is deemed referred to the Standing Committee on Industry, Science and Technology.

Bill C-310, An Act to Provide Certain Rights to Air Passengers, is deemed referred to the Standing Committee on Transport, Infrastructure and Communities.

Bill C-391, An Act to amend the Criminal Code and the Firearms Act (repeal of long-gun registry), is deemed referred to the Standing Committee on Public Safety and National Security.

Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act, is deemed referred to the Standing Committee on Industry, Science and Technology.

Bill C-395, An Act to amend the Employment Insurance Act (labour dispute), is deemed referred to the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities.

Bill C-442, An Act to establish a National Holocaust Monument, is deemed referred to the Standing Committee on Transport, Infrastructure and Communities.

Bill C-464, An Act to amend the Criminal Code (justification for detention in custody), is deemed referred to the Standing Committee on Justice and Human Rights.

Pursuant to Standing Order 97, committees will be required to report on these reinstated private members’ bills within 60 sitting days of this statement.

In addition, one private members’ bill originating in the House of Commons had been read the third time and passed. Therefore, pursuant to Standing Order 86.1, the following bill is deemed adopted at all stages and passed by the House.

Bill C-268, An Act to amend the Criminal Code (minimum sentence for offences involving trafficking of persons under the age of eighteen years). Accordingly, a message will be sent to the Senate to inform it that this House has adopted this bill.

As they are no longer members of this House, all the items standing in the name of Ms. Dawn Black, Mr. Bill Casey and Mr. Paul Crête will be dropped from the order paper.

Consideration of Private Members’ Business will start on Friday, March 5, 2010.

To conclude, hon. members will find at their desks an explanatory note recapitulating these remarks. I trust that these measures will assist the House in understanding how private members' business will be conducted in the third session. In addition, the table can answer any questions members may have.

International AidPetitionsRoutine Proceedings

December 10th, 2009 / 10:20 a.m.


See context

Liberal

Joyce Murray Liberal Vancouver Quadra, BC

Mr. Speaker, I am pleased to rise in the House today to present a petition that calls on Parliament to set a timetable to meet Canada's development assistance commitments, to increase Canada's foreign aid commitments to combat HIV-AIDS, tuberculosis and malaria, and to make the legislative changes necessary for Canada's access to medicines regime to facilitate immediate and sustainable lower cost generic medicines flowing to developing countries. They call on the government to support Bill C-393.

The petition is signed by residents of Vancouver Quadra. It stems from the heroic efforts of the African grandmothers who raise children orphaned by AIDS. They are supported by the efforts of over 200 grandmother groups across Canada.

Drugs and PharmaceuticalsPetitionsRoutine Proceedings

December 10th, 2009 / 10:20 a.m.


See context

NDP

Judy Wasylycia-Leis NDP Winnipeg North, MB

Mr. Speaker, I have three petitions. The first petition has to do with concerns from constituents and others about the 14,000 men, women and children who die every day from tuberculosis, malaria and HIV-AIDS.

The petitioners call upon this House to support Bill C-393, my private member's bill. They are pleased that it received support at second reading, and call upon this House to complete the process and ensure that it becomes law.

International AidPetitionsRoutine Proceedings

December 8th, 2009 / 10:10 a.m.


See context

NDP

Judy Wasylycia-Leis NDP Winnipeg North, MB

Mr. Speaker, I am very pleased to present yet another petition that was organized by the Grandmothers to Grandmothers Campaign in support of my Bill C-393, reforms to the Canada access to medicines regime, and also generally to ensure we meet our millennium development goals.

The petitioners call upon all of us to do our part to ensure that 0.7% of our gross national product goes to development assistance internationally and that we contribute our share to the global fund to fight AIDS, TB and malaria.

I want to thank the grandmothers again for their incredible pioneering work in gathering thousands of petitions in support of Bill C-393, and in their show of courage and conviction to ensure that people around the world benefit from the resources of this rich nation.

Patent ActPetitionsRoutine Proceedings

December 3rd, 2009 / 1:10 p.m.


See context

NDP

Judy Wasylycia-Leis NDP Winnipeg North, MB

Madam Speaker, I am pleased to table a petition that was organized by the Grandmothers for Grandmothers campaign who wanted to see Bill C-393 pass through the House to committee.

They are delighted with the results of the vote in the House last night. They urge all parliamentarians to continue working on the bill to ensure that necessary medications get to those countries that cannot otherwise afford them to deal with such horrible and deathly diseases as HIV and AIDS, tuberculosis and malaria.

On behalf of everyone in the House, I would like to thank the grandmothers again for their great work on this issue.

Patent ActPrivate Members' Business

December 2nd, 2009 / 6 p.m.


See context

The Deputy Speaker Andrew Scheer

The House will now proceed to the taking of the deferred recorded division of the motion at second reading stage of Bill C-393 under private members' business.